Xin Lang Cai Jing·2026-01-12 09:46Core Viewpoint - WuXi AppTec (603259.SH) expects to achieve a net profit attributable to shareholders of approximately RMB 19.151 billion in 2025, representing a year-on-year growth of about 102.65% [1] Group 1: Business Model and Strategy - The company continues to focus on its unique "integrated, end-to-end" CRDMO (Contract Research, Development, and Manufacturing Organization) business model [1] - WuXi AppTec is committed to meeting customer demands for empowerment and is continuously expanding new capabilities and building new production capacity [1] - The company is dedicated to optimizing production processes and improving operational efficiency to drive steady business growth [1] Group 2: Commitment to Clients and Market Impact - WuXi AppTec aims to empower clients effectively and is committed to bringing more new and effective drugs to global patients [1]